CTLA4 and melanoma: There were no statistical differences in the incidence of CTLA-4 polymorphisms between melanoma patients and healthy controls (Table 1), except for JO 31, where the T/T allele was higher in controls (33.3% vs 24.3%) while G/G and G/T was lower (p = 0.047).